Compare XTNT & MTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XTNT | MTC |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.2M | 71.8M |
| IPO Year | N/A | 2019 |
| Metric | XTNT | MTC |
|---|---|---|
| Price | $0.60 | $2.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 188.4K | 32.9K |
| Earning Date | 03-05-2026 | 12-13-2024 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $133,083,000.00 | $2,675,833.00 |
| Revenue This Year | $15.08 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $52.95 | ★ N/A |
| Revenue Growth | 16.88 | ★ 114.77 |
| 52 Week Low | $0.34 | $0.25 |
| 52 Week High | $0.95 | $3.89 |
| Indicator | XTNT | MTC |
|---|---|---|
| Relative Strength Index (RSI) | 35.20 | 43.84 |
| Support Level | $0.60 | $2.70 |
| Resistance Level | $0.67 | $2.99 |
| Average True Range (ATR) | 0.04 | 0.24 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 6.76 | 29.41 |
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.